JP2024105360A5 - - Google Patents

Download PDF

Info

Publication number
JP2024105360A5
JP2024105360A5 JP2024071962A JP2024071962A JP2024105360A5 JP 2024105360 A5 JP2024105360 A5 JP 2024105360A5 JP 2024071962 A JP2024071962 A JP 2024071962A JP 2024071962 A JP2024071962 A JP 2024071962A JP 2024105360 A5 JP2024105360 A5 JP 2024105360A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound
nhc
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024071962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024105360A (ja
Filing date
Publication date
Priority claimed from JP2019032014A external-priority patent/JP6936823B2/ja
Application filed filed Critical
Publication of JP2024105360A publication Critical patent/JP2024105360A/ja
Publication of JP2024105360A5 publication Critical patent/JP2024105360A5/ja
Pending legal-status Critical Current

Links

JP2024071962A 2013-03-15 2024-04-25 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体 Pending JP2024105360A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361792812P 2013-03-15 2013-03-15
US61/792,812 2013-03-15
JP2019032014A JP6936823B2 (ja) 2013-03-15 2019-02-25 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP2021138625A JP7169412B2 (ja) 2013-03-15 2021-08-27 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体
JP2022173722A JP7536064B2 (ja) 2013-03-15 2022-10-28 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022173722A Division JP7536064B2 (ja) 2013-03-15 2022-10-28 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体

Publications (2)

Publication Number Publication Date
JP2024105360A JP2024105360A (ja) 2024-08-06
JP2024105360A5 true JP2024105360A5 (https=) 2025-01-21

Family

ID=51529950

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2016503185A Active JP6165314B2 (ja) 2013-03-15 2014-03-14 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP2017120849A Pending JP2017193567A (ja) 2013-03-15 2017-06-20 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP2019032014A Active JP6936823B2 (ja) 2013-03-15 2019-02-25 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP2021138625A Active JP7169412B2 (ja) 2013-03-15 2021-08-27 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体
JP2022173722A Active JP7536064B2 (ja) 2013-03-15 2022-10-28 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体
JP2024071962A Pending JP2024105360A (ja) 2013-03-15 2024-04-25 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体

Family Applications Before (5)

Application Number Title Priority Date Filing Date
JP2016503185A Active JP6165314B2 (ja) 2013-03-15 2014-03-14 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP2017120849A Pending JP2017193567A (ja) 2013-03-15 2017-06-20 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP2019032014A Active JP6936823B2 (ja) 2013-03-15 2019-02-25 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP2021138625A Active JP7169412B2 (ja) 2013-03-15 2021-08-27 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体
JP2022173722A Active JP7536064B2 (ja) 2013-03-15 2022-10-28 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体

Country Status (18)

Country Link
US (1) US9181223B2 (https=)
EP (1) EP2968286B1 (https=)
JP (6) JP6165314B2 (https=)
KR (5) KR20240013846A (https=)
CN (2) CN105120864B (https=)
AU (5) AU2014233411B2 (https=)
BR (1) BR112015022288B1 (https=)
CA (1) CA2903285C (https=)
DK (1) DK2968286T3 (https=)
ES (1) ES2651165T3 (https=)
IL (4) IL241000B (https=)
MX (1) MX365574B (https=)
NL (1) NL301373I2 (https=)
PH (1) PH12015502114B1 (https=)
PT (1) PT2968286T (https=)
RU (1) RU2015143717A (https=)
SG (1) SG11201507660TA (https=)
WO (1) WO2014145025A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
CA2903285C (en) * 2013-03-15 2021-05-11 Deciphera Pharmaceuticals, Llc 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
AR109179A1 (es) 2016-08-19 2018-11-07 Pfizer Inhibidores de diacilglicerol aciltransferasa 2
EP3632906B1 (en) * 2017-05-24 2023-12-13 Abbisko Therapeutics Co., Ltd. Azaaryl derivative, preparation method therefor, and application thereof for use in pharmacy
US11180495B2 (en) 2017-06-19 2021-11-23 Abbisko Therapeutics Co., Ltd. Nitrogen heteroaryl derivative having CSF1R inhibitory activity, and preparation method therefor and application thereof
IL276398B2 (en) 2018-01-31 2026-03-01 Deciphera Pharmaceuticals Llc Combination therapy for mastocytosis
KR102708177B1 (ko) 2018-01-31 2024-09-23 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양의 치료를 위한 병용 요법
CN110845476B (zh) * 2018-08-21 2022-11-18 上海和誉生物医药科技有限公司 一种高选择性csf1r抑制剂、其制备方法和在药学上的应用
SMT202500389T1 (it) 2018-12-28 2025-11-10 Deciphera Pharmaceuticals Llc Inibitori di csf1r per l'uso nel trattamento di tumori tenosinoviali a cellule giganti
EP3938363A1 (en) 2019-03-11 2022-01-19 Teva Pharmaceuticals International GmbH Solid state forms of ripretinib
MX2021013662A (es) 2019-05-10 2022-03-11 Deciphera Pharmaceuticals Llc Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos.
EP3966207B1 (en) 2019-05-10 2023-11-01 Deciphera Pharmaceuticals, LLC Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
IL325201A (en) 2019-06-17 2026-02-01 Deciphera Pharmaceuticals Llc Aminopyrimidine amide autophagy inhibitors and methods of using them
LT4013412T (lt) 2019-08-12 2026-03-25 Deciphera Pharmaceuticals, Llc Ripretinibas, skirtas virškinamojo trakto stromos navikų gydymui
PT4013412T (pt) 2019-08-12 2026-03-18 Deciphera Pharmaceuticals Llc Ripretinib para o tratamento de tumores estromais gastrointestinais
CN115243681B (zh) 2019-12-30 2024-08-16 德西费拉制药有限责任公司 1-(4-溴-5-(1-乙基-7-(甲氨基)-2-侧氧基-1,2-二氢-1,6-萘啶-3-基)-2-氟苯基)-3-苯基脲的组合物
HRP20231699T1 (hr) 2019-12-30 2024-05-10 Deciphera Pharmaceuticals, Llc Formulacije inhibitora amorfne kinaze i postupci njihove primjene
MX2023005747A (es) 2020-11-18 2023-07-28 Deciphera Pharmaceuticals Llc Inhibidores de gcn2 y perk quinasas y metodos de uso de los mismos.
CN115385896B (zh) * 2021-05-24 2024-11-15 上海和誉生物医药科技有限公司 一种csf-1r抑制剂中间体或其酸式盐的制备方法
CN113880812A (zh) * 2021-11-17 2022-01-04 上海皓元生物医药科技有限公司 一种csf-ir抑制剂的制备方法
KR20240113496A (ko) 2021-12-03 2024-07-22 데시페라 파마슈티칼스, 엘엘씨. Gcn2 및 perk 키나아제 억제제로서의 헤테로고리 화합물
US12319655B2 (en) 2021-12-09 2025-06-03 Deciphera Pharmaceuticals, Llc RAF kinase inhibitors and methods of use thereof
CN118434727A (zh) * 2021-12-31 2024-08-02 上海海雁医药科技有限公司 取代的嘧啶酮衍生物、其药物组合物及医药上的用途
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors
CN117624132B (zh) * 2023-11-28 2026-04-21 上海相辉医药科技有限公司 一种CSF-1R激酶抑制剂Vimseltinib(DCC-3014)的制备方法
WO2025122952A1 (en) * 2023-12-08 2025-06-12 Deciphera Pharmaceuticals, Llc Formulations of vimseltinib
US20250206720A1 (en) 2023-12-08 2025-06-26 Deciphera Pharmaceuticals, Llc Solid forms of an ulk inhibitor
WO2025231106A1 (en) 2024-05-01 2025-11-06 Deciphera Pharmaceuticals, Llc Csf-1r inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080255155A1 (en) * 2006-10-18 2008-10-16 Stephane Raeppel Kinase inhibitors and uses thereof
EP2125781A2 (en) * 2006-12-20 2009-12-02 Amgen Inc. Substituted heterocycles and methods of use
CN102256493A (zh) * 2008-10-29 2011-11-23 迪赛孚尔制药有限公司 表现出抗癌活性和抗增殖活性的环丙烷酰胺及其类似物
US9193719B2 (en) 2013-03-15 2015-11-24 Deciphera Pharmaceuticals, Llc 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
CA2903285C (en) * 2013-03-15 2021-05-11 Deciphera Pharmaceuticals, Llc 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
US9133183B2 (en) * 2013-03-15 2015-09-15 Deciphera Pharmaceuticals, Llc Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities

Similar Documents

Publication Publication Date Title
JP2024105360A5 (https=)
JP2023010738A5 (https=)
IL289629B2 (en) 2-aminopyrimidine-6-one compounds and analogs exhibiting anti-cancer and anti-proliferative activity
CA2407208A1 (en) Process for producing optically active sulfoxide derivative
JP2001516757A5 (https=)
CA2587528A1 (en) Method for preparing n-phenylpyrazole-1-carboxamides
CA2454306A1 (en) Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
RU98119523A (ru) Соединения пиперазина и пиперидина
JP2010525122A5 (https=)
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
RU2000125568A (ru) Производные циклоалкенов, их получение и применение
RU2004124711A (ru) Способ получения производных индолинона
CA2184919A1 (en) New Piperazine Derivatives and Methods for the Preparation Thereof and Compositions Containing the Same
EP1826196A3 (en) Vinyl ether compounds
CA2549431A1 (en) Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same
KR930012748A (ko) 5-(치환 메틸)-2,3-피리딘디카르복시산의 제조에 유용한 5,6-이치환-3-피리딜메틸 암모늄 할라이드 화합물, 및 이들의 제조방법
RU2001120697A (ru) Способ синтеза нитроксиметилфениловых эфиров производных аспирина
KR880006240A (ko) 헥사하이드로-8-하이드록시-2,6-메타노-2h-퀴놀리진-3(4h)-온의 에스테르 및 이의 관련 화합물
RU2005135439A (ru) Производные индена в качестве фармацевтических средств
KR840005719A (ko) 트리아졸 유도체의 제조방법
CA2598224A1 (en) Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
GB1062713A (en) 4'-hydroxy-4'-piperidyl-ketones
DE60313156D1 (de) Amonafidsalze
JP2006528709A5 (https=)